or Try an Advanced Search...

    Progressive Stocks List

    Symbol Grade Name % Change
    EXEL A Exelixis, Inc. 0.72
    CHX B ChampionX Corporation -0.43
    ITT B ITT Corporation 0.81
    FULC D Fulcrum Therapeutics, Inc. 0.14
    LRMR D Larimar Therapeutics, Inc. 1.74
    MIRM D Mirum Pharmaceuticals, Inc. -0.12
    BIIB D Biogen Idec Inc. 3.18
    GLTO F Galecto, Inc. 5.37
    IGT F International Game Technology 0.20
    View As Page of Charts
    Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
    Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo

    Related ETFs - A few ETFs which own one or more of the above listed Progressive stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 7.83
    BIS B ProShares UltraShort Nasdaq Biotechnology 6.85
    FBT D First Trust Amex Biotech Index Fund 6.7
    PXJ A PowerShares Dynamic Oil Services 5.31
    BBP D BioShares Biotechnology Products Fund 5.28
    View all Progressive ETFs...
    Compare ETFs
    Compare FBT to BBP Compare PBE to PXJ Compare PXJ to BBP

        Progressive Stocks Recent News

        Date Stock Title
        Apr 26 BIIB Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
        Apr 26 EXEL Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
        Apr 26 BIIB The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
        Apr 26 EXEL Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?
        Apr 26 BIIB Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
        Apr 25 BIIB Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
        Apr 25 BIIB Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
        Apr 25 BIIB Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
        Apr 25 BIIB Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past year
        Apr 25 MIRM Mirum Pharmaceuticals, Inc. (MIRM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        Apr 25 ITT ITT Recognized as 3-Star Employer by VETS Indexes for Commitment to Hiring and Developing Military Community Members
        Apr 25 BIIB For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
        Apr 25 BIIB Q1 2024 Biogen Inc Earnings Call
        Apr 24 BIIB Why Biogen Stock Leaped Nearly 5% Higher Today
        Apr 24 CHX ChampionX Non-GAAP EPS of $0.50 beats by $0.09, revenue of $922.1M in-line
        Apr 24 CHX ChampionX Reports First Quarter 2024 Results
        Apr 24 BIIB Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
        Apr 24 BIIB Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
        Apr 24 BIIB Biogen (BIIB) Q1 2024 Earnings Call Transcript
        Apr 24 BIIB Biogen: Don’t expect any big acquisitions this year
        Related Industries: Biotechnology Diversified Industrials Drug Manufacturers - Major Gambling Oil & Gas Equipment & Services
        Related Stock Lists: Biotechnology Medicine Cancer Disability Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pump Acid Aerospace Components Aerospace Market Alcohol Alzheimer's Disease Artificial Lift Equipment Asset Integrity Management Ataxia Autoimmune Disorders Automation Technologies Bearings Bile Acid Bingo
        Progressive

        Browse All Tags